Cui, Hao; Hung, Amos C.; Klaver, David W.; Suzuki, Toshiharu; Freeman, Craig; Narkowicz, Christian; Jacobson, Glenn A.; Small, David H.
BACKGROUND Alzheimer's disease (AD) is caused by accumulation of Aβ, which is produced through sequential cleavage of β-amyloid precursor protein (APP) by the β-site APP cleaving enzyme (BACE1) and γ-secretase. Enoxaparin, a low molecular weight form of the glycosaminoglycan (GAG) heparin, has been reported to lower Aβ plaque deposition and improve cognitive function in AD transgenic mice. METHODOLOGY/PRINCIPAL FINDINGS We examined whether heparin and enoxaparin influence APP processing and...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.